Biotechnology research and development are the hallmark of the CZV business model. The company allocates at least 6.5% of its annual revenue to strengthen its R&D efforts.
The R&D Department is staffed with young and dynamic professionals that have extensive scientific experience. Their expertise in the latest technologies provides solutions to the most demanding challenges in the biotechnology industry. The team is moreover engaged in a number of ongoing collaborations with international research institutes and universities to develop new and ambitious projects.
The modern R&D Laboratory's sophisticated equipments enable CZV to develop a strong product pipeline, from the initial research stage to product development.
Moreover, the Regulatory Affairs Department offers specialist knowledge and experience in the field of international pharmaceutical law, which includes dossier submission and obtaining marketing authorizations and has developed an impressive project portfolio.